The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells

Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines

(2014) Vanita Vanas et al.   TUMOR BIOLOGY

microRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation

(2013) Xiu-Li Jin et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways

(2012) Chunmei Wang et al.   JOURNAL OF HEPATOLOGY

Akt2 Regulates All Akt Isoforms and Promotes Resistance to Hypoxia through Induction of miR-21 upon Oxygen Deprivation

(2011) C. Polytarchou et al.   CANCER RESEARCH

Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines

(2011) V. Swaminathan et al.   CANCER RESEARCH

Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

(2011) A Macià et al.   ONCOGENE

Novel protein interactors of urokinase-type plasminogen activator receptor

(2010) Ahmed H. Mekkawy et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EphA2 overexpression promotes ovarian cancer growth

(2010) Chunhua Lu et al.   CANCER BIOLOGY & THERAPY

The role of caveolin1 and sprouty1 in genistein's regulation of vascular smooth muscle cell and endothelial cell proliferation

(2010) QiuLing Xiang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27

(2010) Sangjin Lee et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

(2010) Celine Sabatel et al.   Molecular Cancer

Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility

(2008) Marcel N.A. Bijman et al.   BIOCHEMICAL PHARMACOLOGY